Goodwill, Acquired (Disposed Of) During Period

No definition available.

Name:	opk_GoodwillAcquiredDisposedOfDuringPeriod
Namespace Prefix:	opk_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

+ Details

Name:	us-gaap_GoodwillForeignCurrencyTranslationGainLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

Name:	us-gaap_GoodwillImpairedAccumulatedImpairmentLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.

+ References

No definition available.

+ Details

Name:	us-gaap_GoodwillRollForward
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_ModeXTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_BioReferenceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=opk_PharmaceuticalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_CURNAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_EirGenPharmaLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_FineTechMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_OPKOBiologicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_OpkoChileMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_OPKOHealthEuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_OPKOMexicoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_TransitionTherapeuticsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=opk_DiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=opk_OpkoDiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Composition of Certain Financial Statement Captions - Changes in Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	May 09, 2022	Jan. 01, 2022
Goodwill [Roll Forward]
Goodwill	$ 597,380	$ 595,851		$ 633,874
Cumulative impairment at January 1		(38,023)
Acquisitions, dispositions and other	(173)
Foreign exchange and other	1,702
Goodwill, ending balance	597,380	595,851		633,874
ModeX
Goodwill [Roll Forward]
Goodwill			$ 80,260
Goodwill, ending balance			$ 80,260
BioReference
Goodwill [Roll Forward]
Goodwill	283,000
Goodwill, ending balance	283,000
Pharmaceuticals \| CURNA
Goodwill [Roll Forward]
Goodwill	0			4,827
Cumulative impairment at January 1		(4,827)
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	0			4,827
Pharmaceuticals \| Rayaldee
Goodwill [Roll Forward]
Goodwill	83,090			81,786
Cumulative impairment at January 1		0
Acquisitions, dispositions and other	0
Foreign exchange and other	1,304
Goodwill, ending balance	83,090			81,786
Pharmaceuticals \| FineTech
Goodwill [Roll Forward]
Goodwill	0			11,698
Cumulative impairment at January 1		(11,698)
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	0			11,698
Pharmaceuticals \| ModeX
Goodwill [Roll Forward]
Goodwill	80,259			80,432
Cumulative impairment at January 1		0
Acquisitions, dispositions and other	(173)
Foreign exchange and other	0
Goodwill, ending balance	80,259			80,432
Pharmaceuticals \| OPKO Biologics
Goodwill [Roll Forward]
Goodwill	139,784			139,784
Cumulative impairment at January 1		0
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	139,784			139,784
Pharmaceuticals \| OPKO Chile
Goodwill [Roll Forward]
Goodwill	4,051			3,767
Cumulative impairment at January 1		0
Acquisitions, dispositions and other	0
Foreign exchange and other	284
Goodwill, ending balance	4,051			3,767
Pharmaceuticals \| OPKO Health Europe
Goodwill [Roll Forward]
Goodwill	7,171			7,057
Cumulative impairment at January 1		0
Acquisitions, dispositions and other	0
Foreign exchange and other	114
Goodwill, ending balance	7,171			7,057
Pharmaceuticals \| OPKO Mexico
Goodwill [Roll Forward]
Goodwill	0			100
Cumulative impairment at January 1		(100)
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	0			100
Pharmaceuticals \| Transition Therapeutics
Goodwill [Roll Forward]
Goodwill	0			3,421
Cumulative impairment at January 1		(3,421)
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	0			3,421
Diagnostics \| BioReference
Goodwill [Roll Forward]
Goodwill	283,025			283,025
Cumulative impairment at January 1		0
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	283,025			283,025
Diagnostics \| OPKO Diagnostics
Goodwill [Roll Forward]
Goodwill	0			17,977
Cumulative impairment at January 1		$ (17,977)
Acquisitions, dispositions and other	0
Foreign exchange and other	0
Goodwill, ending balance	$ 0			$ 17,977